VCCC Alliance events are currently being conducted online.
Catch up on previous events and educational content via Open Learning.
If Not Me, Who? If Not Now, When? Close the Care Gap
In 2022, the Union for International Cancer Control will begin a new three-year 'Close the Care Gap' campaign designed to raise awareness about the numerous barriers that exist for people around the world in accessing the cancer care they need. Prof Sanchia Aranda, past president of the UICC and Deputy Chair VCCC Alliance and Dr Kalinda Griffiths, new VCCC Alliance Research and Education Lead for Aboriginal and Torres Strait Islander Health will lead an important discussion.
SunWatch: wearable photodetector for real time UV monitoring
Join Head of the NanoTech Laboratory at Macquarie University, for an informative look at SunWatch, a personalised technology platform to measure sun exposure. This innovation has the potential to save lives and dramatically reduce treatment costs for melanoma and other skin cancers.
Join an interactive, online short workshop series to build your skills and confidence to implement consumer and community involvement in your research. These consumer masterclasses will be facilitated by Anne McKenzie AM, internationally-regarded consumer advocate and engagement consultant.
Join a collaborative team of researchers led by Professor Brian Abbey (La Trobe Institute for Molecular Sciences) and Associate Professor Belinda Parker (Peter MacCallum Cancer Centre), who have been trialling a new alternative technology for cancer detection. NanoMslide: a cutting-edge nanotechnology to transform the humble microscope slide into a potential new tool for cancer diagnosis.
Developing Novel Chimeric Antigen Receptors for Brain Cancer
Join Dr Ryan Cross, postdoctoral researcher in the Jenkins Lab (WEHI), who will explain how the genetic enhancement of white blood cells (T-cells), are used to express a synthetic receptor called a Chimeric Antigen Receptor (CAR). This process can be employed to develop exciting new therapies for brain cancer including Glioblastoma.
Glioblastoma is the most aggressive form of brain cancer with an average life expectancy of just over a year following diagnosis. Unfortunately, there have been no new therapies since the introduction of the chemotherapy drug, Temozolomide, in 2005.
Online workshop: learn how to interpret the reporting of statistical results in clinical studies
This workshop is designed as an introductory level workshop for health professionals who want to better understand how to interpret the reporting of statistical results. The workshop will explore beyond the simple how-to of statistical testing to delve into what is the research question, what is being estimated and interpretation of confidence intervals and p-values.
